Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection

Hyperinflammatory response caused by infections such as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) increases organ failure, intensive care unit admission, and mortality. Cytokine storm in patients with Coronavirus Disease 2019 (COVID-19) drives this pattern of poor clinical outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Creeden, Justin Fortune, Imami, Ali Sajid, Eby, Hunter M., Gillman, Cassidy, Becker, Kathryn N., Reigle, Jim, Andari, Elissar, Pan, Zhixing K., O’Donovan, Sinead M., McCullumsmith, Robert E., McCullumsmith, Cheryl B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Masson SAS. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904450/
https://www.ncbi.nlm.nih.gov/pubmed/33691249
http://dx.doi.org/10.1016/j.biopha.2021.111437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904450/
https://www.ncbi.nlm.nih.gov/pubmed/33691249
http://dx.doi.org/10.1016/j.biopha.2021.111437

Ejemplares similares